SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-15-001590
Filing Date
2015-03-05
Accepted
2015-03-05 17:16:43
Documents
1
Period of Report
2015-02-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4022315salinas_relmada.html 4  
1 OWNERSHIP DOCUMENT f4022315salinas_relmada.xml 4 4390
  Complete submission text file 0001213900-15-001590.txt   5825
Mailing Address 7707 GATEWAY BLVD NEWARK CA 94560
Business Address
Salinas Eliseo Oreste (Reporting) CIK: 0001435756 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55347 | Film No.: 15678241

Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences